Heart failure severity, inappropriate ICD therapy, and novel ICD programming: a MADIT‐RIT substudy

Background The effects of heart failure (HF) severity on risk of inappropriate implantable cardioverter‐defibrillator (ICD) therapy have not been thoroughly investigated. We aimed to study the association between HF severity and inappropriate ICD therapy in MADIT‐RIT. Methods MADIT‐RIT randomized 1,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pacing and clinical electrophysiology 2017-12, Vol.40 (12), p.1405-1411
Hauptverfasser: Daimee, Usama A., Vermilye, Katherine, Rosero, Spencer, Schuger, Claudio D., Daubert, James P., Zareba, Wojciech, McNitt, Scott, Polonsky, Bronislava, Moss, Arthur J., Kutyifa, Valentina
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1411
container_issue 12
container_start_page 1405
container_title Pacing and clinical electrophysiology
container_volume 40
creator Daimee, Usama A.
Vermilye, Katherine
Rosero, Spencer
Schuger, Claudio D.
Daubert, James P.
Zareba, Wojciech
McNitt, Scott
Polonsky, Bronislava
Moss, Arthur J.
Kutyifa, Valentina
description Background The effects of heart failure (HF) severity on risk of inappropriate implantable cardioverter‐defibrillator (ICD) therapy have not been thoroughly investigated. We aimed to study the association between HF severity and inappropriate ICD therapy in MADIT‐RIT. Methods MADIT‐RIT randomized 1,500 patients to three ICD programming arms: conventional (Arm A), high‐rate cut‐off (Arm B: ≥200 beats/min), and delayed therapy (Arm C: 60‐second delay for ≥170 beats/min). We evaluated the association between New York Heart Association (NYHA) class III (n = 256) versus class I–II (n = 251) and inappropriate ICD therapy in Arm A patients with ICD‐only and cardiac resynchronization therapy with defibrillator (CRT‐D). We additionally assessed benefit of novel ICD programming in Arms B and C versus Arm A by NYHA classification. Results In Arm A, the risk of inappropriate therapy was significantly higher in those with NYHA III versus NYHA I–II for both ICD (hazard ratio [HR] = 2.55, confidence interval [CI]: 1.51–4.30, P 
doi_str_mv 10.1111/pace.13216
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1954064594</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1977118324</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4236-d1c2688583561f5b2ad835855a4e4e50bd64c2549e98cfb0947de264330378013</originalsourceid><addsrcrecordid>eNp9kMtKw0AUhgdRbK1ufAAZcCNidK7JxF1pqy0oitR1mCQnmpKbM0mlOx_BZ_RJnFp14cKzmcOZj5-fD6FDSs6pm4tGJ3BOOaP-FupTKYinqAy3UZ9QEXiKq7CH9qxdEEJ8IuQu6rGQSMa430fpFLRpcabzojOALSzB5O3qDOeVbhpTNybXLeDZaIzbZzC6cV-6SnFVL6H4OjvoyeiyzKunS6zx7XA8m3-8vT_M5th2sW27dLWPdjJdWDj4fgfo8WoyH029m7vr2Wh44yXClfFSmjBfKam49GkmY6ZTtyoptQABksSpLxImRQihSrKYhCJIgfmCc8IDRSgfoJNNruv00oFtozK3CRSFrqDubERDJ8cXMhQOPf6DLurOVK6do4KAUsXZmjrdUImprTWQRc5Hqc0qoiRau4_W7qMv9w4--o7s4hLSX_RHtgPoBnjNC1j9ExXdD0eTTegnm1qMfw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1977118324</pqid></control><display><type>article</type><title>Heart failure severity, inappropriate ICD therapy, and novel ICD programming: a MADIT‐RIT substudy</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Daimee, Usama A. ; Vermilye, Katherine ; Rosero, Spencer ; Schuger, Claudio D. ; Daubert, James P. ; Zareba, Wojciech ; McNitt, Scott ; Polonsky, Bronislava ; Moss, Arthur J. ; Kutyifa, Valentina</creator><creatorcontrib>Daimee, Usama A. ; Vermilye, Katherine ; Rosero, Spencer ; Schuger, Claudio D. ; Daubert, James P. ; Zareba, Wojciech ; McNitt, Scott ; Polonsky, Bronislava ; Moss, Arthur J. ; Kutyifa, Valentina</creatorcontrib><description><![CDATA[Background The effects of heart failure (HF) severity on risk of inappropriate implantable cardioverter‐defibrillator (ICD) therapy have not been thoroughly investigated. We aimed to study the association between HF severity and inappropriate ICD therapy in MADIT‐RIT. Methods MADIT‐RIT randomized 1,500 patients to three ICD programming arms: conventional (Arm A), high‐rate cut‐off (Arm B: ≥200 beats/min), and delayed therapy (Arm C: 60‐second delay for ≥170 beats/min). We evaluated the association between New York Heart Association (NYHA) class III (n = 256) versus class I–II (n = 251) and inappropriate ICD therapy in Arm A patients with ICD‐only and cardiac resynchronization therapy with defibrillator (CRT‐D). We additionally assessed benefit of novel ICD programming in Arms B and C versus Arm A by NYHA classification. Results In Arm A, the risk of inappropriate therapy was significantly higher in those with NYHA III versus NYHA I–II for both ICD (hazard ratio [HR] = 2.55, confidence interval [CI]: 1.51–4.30, P < 0.001) and CRT‐D patients (HR = 3.73, CI: 1.14–12.23, P = 0.030). This was consistent for inappropriate ATP and inappropriate ICD therapy < 200 beats/min, but not for inappropriate shocks. Novel ICD programming significantly reduced inappropriate therapy in patients with both NYHA III (Arm B vs Arm A: HR = 0.08, P < 0.001; Arm C vs Arm A: HR = 0.17, P < 0.001) and NYHA I–II (Arm B vs Arm A: HR = 0.25, P < 0.001; Arm C vs Arm A: HR = 0.28, P < 0.001). Conclusion Patients with more severe HF are at increased risk for inappropriate ICD therapy, particularly ATP due to arrhythmias < 200 beats/min. Novel programming with high‐rate cut‐off or delayed detection reduces inappropriate ICD therapies in both mild and moderate HF.]]></description><identifier>ISSN: 0147-8389</identifier><identifier>EISSN: 1540-8159</identifier><identifier>DOI: 10.1111/pace.13216</identifier><identifier>PMID: 29052236</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Cardiac Resynchronization Therapy ; Cardiovascular diseases ; Defibrillators ; Defibrillators, Implantable ; Female ; Heart diseases ; Heart failure ; Heart Failure - therapy ; HF severity ; Humans ; inappropriate ICD therapy ; Male ; Medical Overuse ; Middle Aged ; novel ICD programming ; Randomized Controlled Trials as Topic ; Retrospective Studies ; Severity of Illness Index</subject><ispartof>Pacing and clinical electrophysiology, 2017-12, Vol.40 (12), p.1405-1411</ispartof><rights>2017 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4236-d1c2688583561f5b2ad835855a4e4e50bd64c2549e98cfb0947de264330378013</citedby><cites>FETCH-LOGICAL-c4236-d1c2688583561f5b2ad835855a4e4e50bd64c2549e98cfb0947de264330378013</cites><orcidid>0000-0002-2839-5564</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fpace.13216$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fpace.13216$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29052236$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Daimee, Usama A.</creatorcontrib><creatorcontrib>Vermilye, Katherine</creatorcontrib><creatorcontrib>Rosero, Spencer</creatorcontrib><creatorcontrib>Schuger, Claudio D.</creatorcontrib><creatorcontrib>Daubert, James P.</creatorcontrib><creatorcontrib>Zareba, Wojciech</creatorcontrib><creatorcontrib>McNitt, Scott</creatorcontrib><creatorcontrib>Polonsky, Bronislava</creatorcontrib><creatorcontrib>Moss, Arthur J.</creatorcontrib><creatorcontrib>Kutyifa, Valentina</creatorcontrib><title>Heart failure severity, inappropriate ICD therapy, and novel ICD programming: a MADIT‐RIT substudy</title><title>Pacing and clinical electrophysiology</title><addtitle>Pacing Clin Electrophysiol</addtitle><description><![CDATA[Background The effects of heart failure (HF) severity on risk of inappropriate implantable cardioverter‐defibrillator (ICD) therapy have not been thoroughly investigated. We aimed to study the association between HF severity and inappropriate ICD therapy in MADIT‐RIT. Methods MADIT‐RIT randomized 1,500 patients to three ICD programming arms: conventional (Arm A), high‐rate cut‐off (Arm B: ≥200 beats/min), and delayed therapy (Arm C: 60‐second delay for ≥170 beats/min). We evaluated the association between New York Heart Association (NYHA) class III (n = 256) versus class I–II (n = 251) and inappropriate ICD therapy in Arm A patients with ICD‐only and cardiac resynchronization therapy with defibrillator (CRT‐D). We additionally assessed benefit of novel ICD programming in Arms B and C versus Arm A by NYHA classification. Results In Arm A, the risk of inappropriate therapy was significantly higher in those with NYHA III versus NYHA I–II for both ICD (hazard ratio [HR] = 2.55, confidence interval [CI]: 1.51–4.30, P < 0.001) and CRT‐D patients (HR = 3.73, CI: 1.14–12.23, P = 0.030). This was consistent for inappropriate ATP and inappropriate ICD therapy < 200 beats/min, but not for inappropriate shocks. Novel ICD programming significantly reduced inappropriate therapy in patients with both NYHA III (Arm B vs Arm A: HR = 0.08, P < 0.001; Arm C vs Arm A: HR = 0.17, P < 0.001) and NYHA I–II (Arm B vs Arm A: HR = 0.25, P < 0.001; Arm C vs Arm A: HR = 0.28, P < 0.001). Conclusion Patients with more severe HF are at increased risk for inappropriate ICD therapy, particularly ATP due to arrhythmias < 200 beats/min. Novel programming with high‐rate cut‐off or delayed detection reduces inappropriate ICD therapies in both mild and moderate HF.]]></description><subject>Cardiac Resynchronization Therapy</subject><subject>Cardiovascular diseases</subject><subject>Defibrillators</subject><subject>Defibrillators, Implantable</subject><subject>Female</subject><subject>Heart diseases</subject><subject>Heart failure</subject><subject>Heart Failure - therapy</subject><subject>HF severity</subject><subject>Humans</subject><subject>inappropriate ICD therapy</subject><subject>Male</subject><subject>Medical Overuse</subject><subject>Middle Aged</subject><subject>novel ICD programming</subject><subject>Randomized Controlled Trials as Topic</subject><subject>Retrospective Studies</subject><subject>Severity of Illness Index</subject><issn>0147-8389</issn><issn>1540-8159</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMtKw0AUhgdRbK1ufAAZcCNidK7JxF1pqy0oitR1mCQnmpKbM0mlOx_BZ_RJnFp14cKzmcOZj5-fD6FDSs6pm4tGJ3BOOaP-FupTKYinqAy3UZ9QEXiKq7CH9qxdEEJ8IuQu6rGQSMa430fpFLRpcabzojOALSzB5O3qDOeVbhpTNybXLeDZaIzbZzC6cV-6SnFVL6H4OjvoyeiyzKunS6zx7XA8m3-8vT_M5th2sW27dLWPdjJdWDj4fgfo8WoyH029m7vr2Wh44yXClfFSmjBfKam49GkmY6ZTtyoptQABksSpLxImRQihSrKYhCJIgfmCc8IDRSgfoJNNruv00oFtozK3CRSFrqDubERDJ8cXMhQOPf6DLurOVK6do4KAUsXZmjrdUImprTWQRc5Hqc0qoiRau4_W7qMv9w4--o7s4hLSX_RHtgPoBnjNC1j9ExXdD0eTTegnm1qMfw</recordid><startdate>201712</startdate><enddate>201712</enddate><creator>Daimee, Usama A.</creator><creator>Vermilye, Katherine</creator><creator>Rosero, Spencer</creator><creator>Schuger, Claudio D.</creator><creator>Daubert, James P.</creator><creator>Zareba, Wojciech</creator><creator>McNitt, Scott</creator><creator>Polonsky, Bronislava</creator><creator>Moss, Arthur J.</creator><creator>Kutyifa, Valentina</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2839-5564</orcidid></search><sort><creationdate>201712</creationdate><title>Heart failure severity, inappropriate ICD therapy, and novel ICD programming: a MADIT‐RIT substudy</title><author>Daimee, Usama A. ; Vermilye, Katherine ; Rosero, Spencer ; Schuger, Claudio D. ; Daubert, James P. ; Zareba, Wojciech ; McNitt, Scott ; Polonsky, Bronislava ; Moss, Arthur J. ; Kutyifa, Valentina</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4236-d1c2688583561f5b2ad835855a4e4e50bd64c2549e98cfb0947de264330378013</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Cardiac Resynchronization Therapy</topic><topic>Cardiovascular diseases</topic><topic>Defibrillators</topic><topic>Defibrillators, Implantable</topic><topic>Female</topic><topic>Heart diseases</topic><topic>Heart failure</topic><topic>Heart Failure - therapy</topic><topic>HF severity</topic><topic>Humans</topic><topic>inappropriate ICD therapy</topic><topic>Male</topic><topic>Medical Overuse</topic><topic>Middle Aged</topic><topic>novel ICD programming</topic><topic>Randomized Controlled Trials as Topic</topic><topic>Retrospective Studies</topic><topic>Severity of Illness Index</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Daimee, Usama A.</creatorcontrib><creatorcontrib>Vermilye, Katherine</creatorcontrib><creatorcontrib>Rosero, Spencer</creatorcontrib><creatorcontrib>Schuger, Claudio D.</creatorcontrib><creatorcontrib>Daubert, James P.</creatorcontrib><creatorcontrib>Zareba, Wojciech</creatorcontrib><creatorcontrib>McNitt, Scott</creatorcontrib><creatorcontrib>Polonsky, Bronislava</creatorcontrib><creatorcontrib>Moss, Arthur J.</creatorcontrib><creatorcontrib>Kutyifa, Valentina</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Pacing and clinical electrophysiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Daimee, Usama A.</au><au>Vermilye, Katherine</au><au>Rosero, Spencer</au><au>Schuger, Claudio D.</au><au>Daubert, James P.</au><au>Zareba, Wojciech</au><au>McNitt, Scott</au><au>Polonsky, Bronislava</au><au>Moss, Arthur J.</au><au>Kutyifa, Valentina</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Heart failure severity, inappropriate ICD therapy, and novel ICD programming: a MADIT‐RIT substudy</atitle><jtitle>Pacing and clinical electrophysiology</jtitle><addtitle>Pacing Clin Electrophysiol</addtitle><date>2017-12</date><risdate>2017</risdate><volume>40</volume><issue>12</issue><spage>1405</spage><epage>1411</epage><pages>1405-1411</pages><issn>0147-8389</issn><eissn>1540-8159</eissn><abstract><![CDATA[Background The effects of heart failure (HF) severity on risk of inappropriate implantable cardioverter‐defibrillator (ICD) therapy have not been thoroughly investigated. We aimed to study the association between HF severity and inappropriate ICD therapy in MADIT‐RIT. Methods MADIT‐RIT randomized 1,500 patients to three ICD programming arms: conventional (Arm A), high‐rate cut‐off (Arm B: ≥200 beats/min), and delayed therapy (Arm C: 60‐second delay for ≥170 beats/min). We evaluated the association between New York Heart Association (NYHA) class III (n = 256) versus class I–II (n = 251) and inappropriate ICD therapy in Arm A patients with ICD‐only and cardiac resynchronization therapy with defibrillator (CRT‐D). We additionally assessed benefit of novel ICD programming in Arms B and C versus Arm A by NYHA classification. Results In Arm A, the risk of inappropriate therapy was significantly higher in those with NYHA III versus NYHA I–II for both ICD (hazard ratio [HR] = 2.55, confidence interval [CI]: 1.51–4.30, P < 0.001) and CRT‐D patients (HR = 3.73, CI: 1.14–12.23, P = 0.030). This was consistent for inappropriate ATP and inappropriate ICD therapy < 200 beats/min, but not for inappropriate shocks. Novel ICD programming significantly reduced inappropriate therapy in patients with both NYHA III (Arm B vs Arm A: HR = 0.08, P < 0.001; Arm C vs Arm A: HR = 0.17, P < 0.001) and NYHA I–II (Arm B vs Arm A: HR = 0.25, P < 0.001; Arm C vs Arm A: HR = 0.28, P < 0.001). Conclusion Patients with more severe HF are at increased risk for inappropriate ICD therapy, particularly ATP due to arrhythmias < 200 beats/min. Novel programming with high‐rate cut‐off or delayed detection reduces inappropriate ICD therapies in both mild and moderate HF.]]></abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>29052236</pmid><doi>10.1111/pace.13216</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-2839-5564</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0147-8389
ispartof Pacing and clinical electrophysiology, 2017-12, Vol.40 (12), p.1405-1411
issn 0147-8389
1540-8159
language eng
recordid cdi_proquest_miscellaneous_1954064594
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Cardiac Resynchronization Therapy
Cardiovascular diseases
Defibrillators
Defibrillators, Implantable
Female
Heart diseases
Heart failure
Heart Failure - therapy
HF severity
Humans
inappropriate ICD therapy
Male
Medical Overuse
Middle Aged
novel ICD programming
Randomized Controlled Trials as Topic
Retrospective Studies
Severity of Illness Index
title Heart failure severity, inappropriate ICD therapy, and novel ICD programming: a MADIT‐RIT substudy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T02%3A11%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Heart%20failure%20severity,%20inappropriate%20ICD%20therapy,%20and%20novel%20ICD%20programming:%20a%20MADIT%E2%80%90RIT%20substudy&rft.jtitle=Pacing%20and%20clinical%20electrophysiology&rft.au=Daimee,%20Usama%20A.&rft.date=2017-12&rft.volume=40&rft.issue=12&rft.spage=1405&rft.epage=1411&rft.pages=1405-1411&rft.issn=0147-8389&rft.eissn=1540-8159&rft_id=info:doi/10.1111/pace.13216&rft_dat=%3Cproquest_cross%3E1977118324%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1977118324&rft_id=info:pmid/29052236&rfr_iscdi=true